Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Research priority sits at the center of this dementia and brain health question.
Research priority setting exercises directly engage Alzheimer’s stakeholders—patients, family caregivers, healthcare providers, and researchers—in identifying which questions matter most for advancing dementia care and prevention. These structured exercises move beyond what researchers alone believe is important and instead center on the real-world challenges that people living with Alzheimer’s disease and their families face every day.
When a caregiver spends eight hours a day managing behavioral symptoms that exhaust them, they may prioritize research into non-pharmaceutical interventions for agitation over studies on biomarker detection that take years to translate into clinical use. These exercises have become increasingly central to how major research funding agencies and institutions prioritize their investments. Rather than funding decisions made solely by scientific committees, stakeholder engagement exercises ensure that the research agenda reflects both scientific merit and practical relevance to the people who stand to benefit most.
Table of Contents
- Why Do Alzheimer’s Research Initiatives Need Direct Stakeholder Input?
- How Priority-Setting Exercises Create Meaningful Engagement
- Real-World Examples of Priority-Setting in Action
- Putting Priority-Setting Exercises Into Practice
- Challenges That Can Undermine Effective Stakeholder Engagement
- Measuring Whether Priority-Setting Exercises Actually Work
- The Evolving Landscape of Stakeholder-Centered Research
- Conclusion
- Frequently Asked Questions
Why Do Alzheimer’s Research Initiatives Need Direct Stakeholder Input?
Stakeholders bring knowledge that researchers working in isolation often overlook. A patient diagnosed with early-stage Alzheimer’s knows firsthand how cognitive decline affects their ability to manage medications, handle finances, or maintain relationships. Family caregivers understand the gaps in care support and the emotional toll of watching someone they love gradually lose their independence. These lived experiences reveal research priorities that pure scientific inquiry might miss. For example, while neurobiologists might focus on understanding amyloid plaques, caregivers consistently prioritize research into interventions that delay functional decline—because functional ability directly determines quality of life and whether someone can remain in their home. The Alzheimer’s Association’s research priority-setting exercises have revealed that stakeholders frequently identify implementation science as a top priority.
This includes research on how to get proven interventions into real-world practice settings more quickly. Academic researchers, by contrast, sometimes prioritize basic science research with uncertain timelines for clinical application. This divergence in priorities isn’t a flaw in stakeholder judgment—it reflects the urgency felt by people living with the disease who don’t have decades to wait for theoretical advances to become practical tools. Involving stakeholders also builds trust in the research enterprise itself. When people with dementia and their caregivers see their voices shape the research agenda, they become more willing to participate in studies. This increased participation improves the quality of research and makes it more representative of the broader population affected by Alzheimer’s disease.
How Priority-Setting Exercises Create Meaningful Engagement
Effective priority-setting exercises combine multiple engagement methods to reach diverse stakeholder groups. These typically include online surveys, small-group workshops, large community forums, and one-on-one interviews. The reason for this mix is that different stakeholders have different communication preferences and constraints. A working caregiver juggling a full-time job and care responsibilities may only be able to participate in a brief online survey, while a retired person might have time for a four-hour workshop. A person with moderate cognitive decline might prefer a face-to-face conversation with trained facilitators rather than completing a written questionnaire.
One important limitation of these exercises is that they don’t always reach the most marginalized populations. Stakeholders with advanced dementia, those without internet access, non-English speakers, and people in under-resourced communities are often underrepresented in priority-setting efforts. This creates a risk that the resulting research priorities reflect the needs of more privileged groups while missing critical gaps for populations with the greatest disparities in dementia care. A priority-setting exercise conducted primarily online and in English will inevitably miss the perspectives of Spanish-speaking communities, immigrant populations, and those without reliable internet access—even though these populations have distinct needs and face unique barriers to accessing dementia research and care. The best priority-setting exercises build in deliberate strategies to reach underrepresented groups, including providing interpretation services, conducting exercises in community settings where people naturally gather, and partnering with trusted community organizations rather than only working through academic institutions.
Real-World Examples of Priority-Setting in Action
The National Institutes of health‘s National Institute on Aging collaborated with stakeholders to identify research priorities for cognitive health and related biological mechanisms. Through a series of workshops and surveys involving over 1,200 people, including patients, caregivers, healthcare providers, and researchers, they identified priorities that reshaped funding. Behavioral and social factors that affect cognitive aging emerged as a top priority—reflecting stakeholder recognition that lifestyle, social engagement, and mental health shape dementia risk in ways that pure neuroscience research might undervalue. The Dementia Platform UK’s priority-setting partnership engaged over 3,000 people living with dementia, family members, and health professionals in identifying research priorities for dementia care and support.
The exercise revealed that stakeholders wanted more research on what helps people live well with dementia in the present, rather than exclusively focusing on future prevention or cure. This shifted perspectives within the research community about the timeline and focus of meaningful dementia research. Many researchers had assumed that the most important work involved either prevention (stopping the disease before it starts) or seeking a cure. But stakeholders pointed out that millions of people are living with Alzheimer’s right now, and improving their daily lives deserves urgent research attention.
Putting Priority-Setting Exercises Into Practice
Implementing stakeholder engagement requires dedicated infrastructure and funding that many research institutions lack. A robust priority-setting exercise costs money—to conduct surveys, hold in-person meetings, provide childcare and transportation for participants, compensate stakeholder participants for their time, and hire skilled facilitators trained in engagement methods. An organization that invests $50,000 in a thorough priority-setting exercise versus simply allowing a scientific advisory board to decide research directions will produce different results. The exercise takes longer and may surface priorities that research funders initially hadn’t considered.
But the tradeoff is that the resulting research agenda has legitimate community backing and is more likely to address problems that matter to the people affected. Research institutions are increasingly embedding stakeholder engagement into their regular operations rather than treating it as a one-time event. The Cure Alzheimer’s Fund, for example, established an ongoing patient and caregiver advisory council that provides input throughout the funding process, not just at the priority-setting stage. This continuous engagement model ensures that as circumstances change—as new treatments emerge, as new understanding develops—stakeholder input remains current and integrated.
Challenges That Can Undermine Effective Stakeholder Engagement
Tokenism represents a significant risk in priority-setting exercises. When organizations include stakeholders in research planning but don’t actually use the input to change decision-making, stakeholders rightfully feel manipulated rather than empowered. They’ve invested time and emotional labor sharing their perspectives, but if leadership ignores the results and funds the research it would have funded anyway, trust erodes. This isn’t hypothetical—some stakeholder engagement efforts have been criticized for including diverse voices without demonstrating how those voices shaped outcomes. Another challenge is the difficulty of synthesizing stakeholder input into actionable research priorities.
When surveys involve thousands of people, priorities often cluster in ways that seem contradictory. Some stakeholders prioritize research on prevention for those at risk; others want research on interventions for those already diagnosed. Some want research to speed toward cure; others want research on living better with disease now. Researchers and funders must then make difficult judgment calls about how to weight different stakeholder perspectives. A common warning: if priority-setting exercises don’t include transparent explanation of how results influenced actual funding decisions, they can increase stakeholder frustration rather than reducing it.
Measuring Whether Priority-Setting Exercises Actually Work
Determining the impact of stakeholder engagement exercises requires clear metrics and honest assessment. Some organizations track whether research proposals align with identified stakeholder priorities. The European Research Council, which has increasingly incorporated stakeholder input into dementia research priority-setting, reports that funding decisions are becoming more aligned with community-identified needs.
Measuring alignment, however, only captures whether priorities were heard—not whether the resulting research actually improves outcomes for people with dementia. More meaningful impact assessment examines whether research shaped by stakeholder engagement produces findings that people with dementia and caregivers find practically useful. This requires long-term tracking as research projects progress from funding through completion and dissemination. Early evidence suggests that research prioritized through stakeholder engagement processes does produce findings that are more likely to be translated into practice changes, but more rigorous evaluation is needed to confirm this pattern across different research domains.
The Evolving Landscape of Stakeholder-Centered Research
As recognition grows that Alzheimer’s research must center stakeholder voices, the infrastructure supporting these exercises continues to develop. Research training programs now include curriculum on community engagement methods. Funding agencies increasingly require demonstration of stakeholder engagement as a condition of grants.
Patient advocacy organizations are building capacity to participate in research governance more effectively. The future likely holds more sophisticated methods for continuous stakeholder input. Rather than isolated priority-setting exercises every few years, technology and new engagement models may enable ongoing participation from people with dementia and caregivers in research planning. This evolution reflects a fundamental shift: moving from research conducted by experts for patients, toward research conducted in partnership with all stakeholders as equals.
Conclusion
Research priority-setting exercises that engage Alzheimer’s stakeholders—patients, caregivers, healthcare providers, and researchers working together—produce research agendas that better reflect real-world needs and priorities. These exercises reveal that people affected by dementia often prioritize practical interventions, implementation science, and quality-of-life research alongside the biomedical investigations that research institutions might otherwise emphasize alone. The exercise itself builds trust and increases willingness to participate in research.
If you or a family member is affected by Alzheimer’s disease, look for opportunities to participate in research priority-setting exercises through your local Alzheimer’s Association chapter, medical center, or research institutions. Your perspective matters—not as a gesture of inclusion, but as essential input that shapes how scientific resources are invested in addressing dementia. Research organizations that genuinely want to advance dementia care must build stakeholder engagement into their decision-making structures as a permanent feature, not a one-time event.
Frequently Asked Questions
What is a research priority-setting exercise?
A research priority-setting exercise is a structured process where researchers, patients, caregivers, and other stakeholders work together to identify which research questions are most important to address. These exercises use surveys, workshops, and discussions to gather input, then synthesize that input into a ranked or organized list of research priorities that helps guide funding and research planning.
Who participates in these exercises?
Participants typically include people with Alzheimer’s disease or mild cognitive impairment, family caregivers, healthcare providers (doctors, nurses, social workers), researchers, research funders, and representatives from advocacy organizations. Some exercises specifically recruit underrepresented groups to ensure diverse perspectives are included.
How does stakeholder input actually change research funding?
When stakeholders identify a priority, research funders review existing research gaps in that area, develop funding opportunity announcements, and award grants to researchers proposing to address the prioritized questions. However, not every stakeholder-identified priority becomes funded—research institutions also consider scientific feasibility, existing expertise, and strategic fit. The key is that priorities identified through stakeholder engagement become part of the landscape that funders explicitly consider.
Why might a caregiver’s priorities differ from a researcher’s priorities?
Caregivers live daily with the immediate impacts of Alzheimer’s—managing behavioral symptoms, navigating care systems, experiencing emotional burden. This lived experience shapes what feels urgent and important. Researchers trained in basic science might prioritize understanding disease mechanisms without considering how long it takes to translate that understanding into treatments people can access. Both perspectives are valuable; stakeholder engagement ensures both are heard.
What happens if stakeholders identify priorities that researchers say aren’t scientifically feasible?
This is a genuine tension in priority-setting work. A caregiver might prioritize finding a cure in the next five years; researchers know that timeline isn’t realistic with current science. In these cases, the best exercises help translate stakeholder priorities into scientifically feasible research questions that address underlying concerns. Instead of “cure Alzheimer’s in five years,” research might focus on “develop interventions that significantly slow cognitive decline” or “improve quality of life for people with moderate dementia.”
How can I participate in research priority-setting if I’m affected by Alzheimer’s disease?
Contact your local Alzheimer’s Association chapter, ask your healthcare provider about involvement opportunities, or search for “Alzheimer’s research priority setting” along with your region to identify organizations conducting these exercises. Some universities and medical centers have patient and caregiver advisory boards that welcome participation.
You Might Also Like
- Scientific Publication Trends Reflect Growing Alzheimer’s Research Activity
- Team-Based Fundraising Events Build Community Around Alzheimer’s Cause
- Pharmaceutical M&A Activity Influenced by Alzheimer’s Drug Assets
For more, see National Institute on Aging.
